Researchers find combination can enhance ipilimumab immunotherapy

Source: Medical Press, June 2018

Using a targeted therapy to block a protein that suppresses T cell activity could improve cancer treatment with immune checkpoint inhibitors, researchers at The University of Texas MD Anderson Cancer Center report today in the Journal of Clinical Investigation.